nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP3A7—Ifosfamide—testicular cancer	0.0807	0.177	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0807	0.177	CbGbCtD
Risperidone—CYP3A5—Ifosfamide—testicular cancer	0.0605	0.133	CbGbCtD
Risperidone—ADRA1B—vas deferens—testicular cancer	0.0426	0.3	CbGeAlD
Risperidone—ABCB1—Dactinomycin—testicular cancer	0.0334	0.0733	CbGbCtD
Risperidone—CYP3A5—Etoposide—testicular cancer	0.0289	0.0635	CbGbCtD
Risperidone—HTR7—vas deferens—testicular cancer	0.0248	0.175	CbGeAlD
Risperidone—CYP3A4—Ifosfamide—testicular cancer	0.0236	0.0519	CbGbCtD
Risperidone—ABCB1—Vinblastine—testicular cancer	0.0209	0.0459	CbGbCtD
Risperidone—CYP2D6—Vinblastine—testicular cancer	0.0197	0.0433	CbGbCtD
Risperidone—ABCB1—Cisplatin—testicular cancer	0.0192	0.0421	CbGbCtD
Risperidone—ABCB1—Etoposide—testicular cancer	0.0188	0.0414	CbGbCtD
Risperidone—H1F0—semen—testicular cancer	0.0143	0.101	CbGeAlD
Risperidone—ABCB1—Doxorubicin—testicular cancer	0.0128	0.0282	CbGbCtD
Risperidone—CYP3A4—Vinblastine—testicular cancer	0.0125	0.0275	CbGbCtD
Risperidone—ABCB1—Methotrexate—testicular cancer	0.0124	0.0273	CbGbCtD
Risperidone—CYP2D6—Doxorubicin—testicular cancer	0.0121	0.0266	CbGbCtD
Risperidone—CYP3A4—Etoposide—testicular cancer	0.0113	0.0248	CbGbCtD
Risperidone—HTR7—vein—testicular cancer	0.0105	0.0742	CbGeAlD
Risperidone—CYP3A4—Doxorubicin—testicular cancer	0.00769	0.0169	CbGbCtD
Risperidone—HTR2A—vein—testicular cancer	0.00657	0.0463	CbGeAlD
Risperidone—H1F0—embryo—testicular cancer	0.00323	0.0228	CbGeAlD
Risperidone—DRD4—testis—testicular cancer	0.0031	0.0218	CbGeAlD
Risperidone—H1F0—seminal vesicle—testicular cancer	0.00304	0.0214	CbGeAlD
Risperidone—H1F0—gonad—testicular cancer	0.00219	0.0154	CbGeAlD
Risperidone—H1F0—female gonad—testicular cancer	0.00178	0.0125	CbGeAlD
Risperidone—KCNH2—seminal vesicle—testicular cancer	0.00175	0.0123	CbGeAlD
Risperidone—ADRA2C—seminal vesicle—testicular cancer	0.00172	0.0121	CbGeAlD
Risperidone—H1F0—testis—testicular cancer	0.00158	0.0111	CbGeAlD
Risperidone—ADRA2A—seminal vesicle—testicular cancer	0.00137	0.00967	CbGeAlD
Risperidone—HTR7—gonad—testicular cancer	0.00135	0.00953	CbGeAlD
Risperidone—HTR2A—embryo—testicular cancer	0.00124	0.00875	CbGeAlD
Risperidone—H1F0—lymph node—testicular cancer	0.00115	0.00807	CbGeAlD
Risperidone—KCNH2—female gonad—testicular cancer	0.00103	0.00721	CbGeAlD
Risperidone—ADRA2C—female gonad—testicular cancer	0.00101	0.00712	CbGeAlD
Risperidone—ADRA2A—gonad—testicular cancer	0.000993	0.00699	CbGeAlD
Risperidone—HTR7—testis—testicular cancer	0.000976	0.00687	CbGeAlD
Risperidone—DRD2—testis—testicular cancer	0.000923	0.00649	CbGeAlD
Risperidone—KCNH2—testis—testicular cancer	0.000909	0.0064	CbGeAlD
Risperidone—ADRA2C—testis—testicular cancer	0.000897	0.00631	CbGeAlD
Risperidone—CYP3A5—female gonad—testicular cancer	0.000847	0.00596	CbGeAlD
Risperidone—HTR2A—gonad—testicular cancer	0.000844	0.00594	CbGeAlD
Risperidone—HTR2B—lymph node—testicular cancer	0.000826	0.00581	CbGeAlD
Risperidone—HRH1—female gonad—testicular cancer	0.000822	0.00578	CbGeAlD
Risperidone—ABCB1—embryo—testicular cancer	0.000815	0.00574	CbGeAlD
Risperidone—ADRA2A—female gonad—testicular cancer	0.000807	0.00568	CbGeAlD
Risperidone—ABCB1—seminal vesicle—testicular cancer	0.000766	0.00539	CbGeAlD
Risperidone—HRH1—testis—testicular cancer	0.000729	0.00513	CbGeAlD
Risperidone—ADRA2A—testis—testicular cancer	0.000716	0.00504	CbGeAlD
Risperidone—KCNH2—lymph node—testicular cancer	0.000659	0.00464	CbGeAlD
Risperidone—ADRA2C—lymph node—testicular cancer	0.00065	0.00458	CbGeAlD
Risperidone—CYP2D6—female gonad—testicular cancer	0.000625	0.0044	CbGeAlD
Risperidone—HTR2A—testis—testicular cancer	0.000609	0.00428	CbGeAlD
Risperidone—CYP2D6—testis—testicular cancer	0.000554	0.0039	CbGeAlD
Risperidone—ABCB1—gonad—testicular cancer	0.000553	0.00389	CbGeAlD
Risperidone—HRH1—lymph node—testicular cancer	0.000528	0.00372	CbGeAlD
Risperidone—ADRA2A—lymph node—testicular cancer	0.000519	0.00365	CbGeAlD
Risperidone—ABCB1—female gonad—testicular cancer	0.00045	0.00316	CbGeAlD
Risperidone—ABCB1—testis—testicular cancer	0.000399	0.00281	CbGeAlD
Risperidone—ABCB1—lymph node—testicular cancer	0.000289	0.00203	CbGeAlD
Risperidone—Oedema peripheral—Epirubicin—testicular cancer	0.000128	0.000318	CcSEcCtD
Risperidone—Haematuria—Doxorubicin—testicular cancer	0.000128	0.000317	CcSEcCtD
Risperidone—Connective tissue disorder—Epirubicin—testicular cancer	0.000128	0.000317	CcSEcCtD
Risperidone—Urethral disorder—Epirubicin—testicular cancer	0.000127	0.000316	CcSEcCtD
Risperidone—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000127	0.000315	CcSEcCtD
Risperidone—Epistaxis—Doxorubicin—testicular cancer	0.000126	0.000314	CcSEcCtD
Risperidone—Angiopathy—Methotrexate—testicular cancer	0.000126	0.000313	CcSEcCtD
Risperidone—Sinusitis—Doxorubicin—testicular cancer	0.000126	0.000312	CcSEcCtD
Risperidone—Immune system disorder—Methotrexate—testicular cancer	0.000126	0.000312	CcSEcCtD
Risperidone—Visual impairment—Epirubicin—testicular cancer	0.000125	0.000311	CcSEcCtD
Risperidone—Mediastinal disorder—Methotrexate—testicular cancer	0.000125	0.000311	CcSEcCtD
Risperidone—Agranulocytosis—Doxorubicin—testicular cancer	0.000125	0.000311	CcSEcCtD
Risperidone—Chills—Methotrexate—testicular cancer	0.000125	0.00031	CcSEcCtD
Risperidone—Nausea—Ifosfamide—testicular cancer	0.000124	0.000308	CcSEcCtD
Risperidone—Diarrhoea—Cisplatin—testicular cancer	0.000123	0.000306	CcSEcCtD
Risperidone—Erythema multiforme—Epirubicin—testicular cancer	0.000123	0.000305	CcSEcCtD
Risperidone—Alopecia—Methotrexate—testicular cancer	0.000123	0.000305	CcSEcCtD
Risperidone—Bradycardia—Doxorubicin—testicular cancer	0.000122	0.000304	CcSEcCtD
Risperidone—Mental disorder—Methotrexate—testicular cancer	0.000122	0.000302	CcSEcCtD
Risperidone—Eye disorder—Epirubicin—testicular cancer	0.000122	0.000302	CcSEcCtD
Risperidone—Hypersensitivity—Etoposide—testicular cancer	0.000121	0.000301	CcSEcCtD
Risperidone—Tinnitus—Epirubicin—testicular cancer	0.000121	0.000301	CcSEcCtD
Risperidone—Erythema—Methotrexate—testicular cancer	0.000121	0.0003	CcSEcCtD
Risperidone—Malnutrition—Methotrexate—testicular cancer	0.000121	0.0003	CcSEcCtD
Risperidone—Haemoglobin—Doxorubicin—testicular cancer	0.000121	0.0003	CcSEcCtD
Risperidone—Flushing—Epirubicin—testicular cancer	0.000121	0.0003	CcSEcCtD
Risperidone—Cardiac disorder—Epirubicin—testicular cancer	0.000121	0.0003	CcSEcCtD
Risperidone—Rhinitis—Doxorubicin—testicular cancer	0.000121	0.000299	CcSEcCtD
Risperidone—Hepatitis—Doxorubicin—testicular cancer	0.00012	0.000299	CcSEcCtD
Risperidone—Haemorrhage—Doxorubicin—testicular cancer	0.00012	0.000299	CcSEcCtD
Risperidone—Hypoaesthesia—Doxorubicin—testicular cancer	0.00012	0.000297	CcSEcCtD
Risperidone—Pharyngitis—Doxorubicin—testicular cancer	0.000119	0.000296	CcSEcCtD
Risperidone—Urinary tract disorder—Doxorubicin—testicular cancer	0.000119	0.000295	CcSEcCtD
Risperidone—Oedema peripheral—Doxorubicin—testicular cancer	0.000119	0.000294	CcSEcCtD
Risperidone—Dysgeusia—Methotrexate—testicular cancer	0.000118	0.000294	CcSEcCtD
Risperidone—Asthenia—Etoposide—testicular cancer	0.000118	0.000294	CcSEcCtD
Risperidone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000118	0.000294	CcSEcCtD
Risperidone—Angiopathy—Epirubicin—testicular cancer	0.000118	0.000293	CcSEcCtD
Risperidone—Urethral disorder—Doxorubicin—testicular cancer	0.000118	0.000293	CcSEcCtD
Risperidone—Immune system disorder—Epirubicin—testicular cancer	0.000117	0.000292	CcSEcCtD
Risperidone—Mediastinal disorder—Epirubicin—testicular cancer	0.000117	0.000291	CcSEcCtD
Risperidone—Back pain—Methotrexate—testicular cancer	0.000117	0.00029	CcSEcCtD
Risperidone—Chills—Epirubicin—testicular cancer	0.000117	0.00029	CcSEcCtD
Risperidone—Pruritus—Etoposide—testicular cancer	0.000117	0.000289	CcSEcCtD
Risperidone—Arrhythmia—Epirubicin—testicular cancer	0.000116	0.000288	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—testicular cancer	0.000116	0.000288	CcSEcCtD
Risperidone—Alopecia—Epirubicin—testicular cancer	0.000115	0.000285	CcSEcCtD
Risperidone—Vomiting—Cisplatin—testicular cancer	0.000114	0.000284	CcSEcCtD
Risperidone—Vision blurred—Methotrexate—testicular cancer	0.000114	0.000283	CcSEcCtD
Risperidone—Mental disorder—Epirubicin—testicular cancer	0.000114	0.000283	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—testicular cancer	0.000114	0.000282	CcSEcCtD
Risperidone—Rash—Cisplatin—testicular cancer	0.000113	0.000282	CcSEcCtD
Risperidone—Dermatitis—Cisplatin—testicular cancer	0.000113	0.000281	CcSEcCtD
Risperidone—Malnutrition—Epirubicin—testicular cancer	0.000113	0.000281	CcSEcCtD
Risperidone—Erythema—Epirubicin—testicular cancer	0.000113	0.000281	CcSEcCtD
Risperidone—Diarrhoea—Etoposide—testicular cancer	0.000113	0.00028	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—testicular cancer	0.000112	0.000279	CcSEcCtD
Risperidone—Ill-defined disorder—Methotrexate—testicular cancer	0.000112	0.000279	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—testicular cancer	0.000112	0.000278	CcSEcCtD
Risperidone—Anaemia—Methotrexate—testicular cancer	0.000112	0.000278	CcSEcCtD
Risperidone—Flushing—Doxorubicin—testicular cancer	0.000112	0.000277	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—testicular cancer	0.000112	0.000277	CcSEcCtD
Risperidone—Flatulence—Epirubicin—testicular cancer	0.000112	0.000277	CcSEcCtD
Risperidone—Tension—Epirubicin—testicular cancer	0.000111	0.000276	CcSEcCtD
Risperidone—Dysgeusia—Epirubicin—testicular cancer	0.000111	0.000275	CcSEcCtD
Risperidone—Nervousness—Epirubicin—testicular cancer	0.00011	0.000273	CcSEcCtD
Risperidone—Back pain—Epirubicin—testicular cancer	0.000109	0.000272	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—testicular cancer	0.000109	0.000271	CcSEcCtD
Risperidone—Malaise—Methotrexate—testicular cancer	0.000109	0.000271	CcSEcCtD
Risperidone—Dizziness—Etoposide—testicular cancer	0.000109	0.000271	CcSEcCtD
Risperidone—Muscle spasms—Epirubicin—testicular cancer	0.000109	0.00027	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—testicular cancer	0.000109	0.00027	CcSEcCtD
Risperidone—Vertigo—Methotrexate—testicular cancer	0.000109	0.00027	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—testicular cancer	0.000108	0.000269	CcSEcCtD
Risperidone—Leukopenia—Methotrexate—testicular cancer	0.000108	0.000269	CcSEcCtD
Risperidone—Chills—Doxorubicin—testicular cancer	0.000108	0.000268	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—testicular cancer	0.000107	0.000267	CcSEcCtD
Risperidone—Nausea—Cisplatin—testicular cancer	0.000107	0.000265	CcSEcCtD
Risperidone—Vision blurred—Epirubicin—testicular cancer	0.000107	0.000265	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—testicular cancer	0.000106	0.000264	CcSEcCtD
Risperidone—Cough—Methotrexate—testicular cancer	0.000106	0.000262	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—testicular cancer	0.000105	0.000262	CcSEcCtD
Risperidone—Ill-defined disorder—Epirubicin—testicular cancer	0.000105	0.000261	CcSEcCtD
Risperidone—Convulsion—Methotrexate—testicular cancer	0.000105	0.00026	CcSEcCtD
Risperidone—Vomiting—Etoposide—testicular cancer	0.000105	0.00026	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—testicular cancer	0.000105	0.00026	CcSEcCtD
Risperidone—Erythema—Doxorubicin—testicular cancer	0.000105	0.00026	CcSEcCtD
Risperidone—Anaemia—Epirubicin—testicular cancer	0.000105	0.00026	CcSEcCtD
Risperidone—Agitation—Epirubicin—testicular cancer	0.000104	0.000258	CcSEcCtD
Risperidone—Rash—Etoposide—testicular cancer	0.000104	0.000258	CcSEcCtD
Risperidone—Dermatitis—Etoposide—testicular cancer	0.000104	0.000258	CcSEcCtD
Risperidone—Headache—Etoposide—testicular cancer	0.000103	0.000256	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—testicular cancer	0.000103	0.000256	CcSEcCtD
Risperidone—Chest pain—Methotrexate—testicular cancer	0.000103	0.000256	CcSEcCtD
Risperidone—Myalgia—Methotrexate—testicular cancer	0.000103	0.000256	CcSEcCtD
Risperidone—Arthralgia—Methotrexate—testicular cancer	0.000103	0.000256	CcSEcCtD
Risperidone—Tension—Doxorubicin—testicular cancer	0.000103	0.000255	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—testicular cancer	0.000103	0.000255	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000102	0.000254	CcSEcCtD
Risperidone—Malaise—Epirubicin—testicular cancer	0.000102	0.000253	CcSEcCtD
Risperidone—Discomfort—Methotrexate—testicular cancer	0.000102	0.000253	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—testicular cancer	0.000102	0.000253	CcSEcCtD
Risperidone—Vertigo—Epirubicin—testicular cancer	0.000102	0.000252	CcSEcCtD
Risperidone—Syncope—Epirubicin—testicular cancer	0.000102	0.000252	CcSEcCtD
Risperidone—Leukopenia—Epirubicin—testicular cancer	0.000101	0.000252	CcSEcCtD
Risperidone—Back pain—Doxorubicin—testicular cancer	0.000101	0.000252	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—testicular cancer	0.000101	0.00025	CcSEcCtD
Risperidone—Palpitations—Epirubicin—testicular cancer	0.0001	0.000248	CcSEcCtD
Risperidone—Confusional state—Methotrexate—testicular cancer	9.95e-05	0.000247	CcSEcCtD
Risperidone—Loss of consciousness—Epirubicin—testicular cancer	9.95e-05	0.000247	CcSEcCtD
Risperidone—Cough—Epirubicin—testicular cancer	9.88e-05	0.000245	CcSEcCtD
Risperidone—Anaphylactic shock—Methotrexate—testicular cancer	9.87e-05	0.000245	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—testicular cancer	9.87e-05	0.000245	CcSEcCtD
Risperidone—Convulsion—Epirubicin—testicular cancer	9.81e-05	0.000243	CcSEcCtD
Risperidone—Infection—Methotrexate—testicular cancer	9.81e-05	0.000243	CcSEcCtD
Risperidone—Nausea—Etoposide—testicular cancer	9.79e-05	0.000243	CcSEcCtD
Risperidone—Hypertension—Epirubicin—testicular cancer	9.77e-05	0.000243	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—testicular cancer	9.72e-05	0.000241	CcSEcCtD
Risperidone—Nervous system disorder—Methotrexate—testicular cancer	9.68e-05	0.00024	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—testicular cancer	9.68e-05	0.00024	CcSEcCtD
Risperidone—Thrombocytopenia—Methotrexate—testicular cancer	9.67e-05	0.00024	CcSEcCtD
Risperidone—Chest pain—Epirubicin—testicular cancer	9.64e-05	0.000239	CcSEcCtD
Risperidone—Arthralgia—Epirubicin—testicular cancer	9.64e-05	0.000239	CcSEcCtD
Risperidone—Myalgia—Epirubicin—testicular cancer	9.64e-05	0.000239	CcSEcCtD
Risperidone—Agitation—Doxorubicin—testicular cancer	9.63e-05	0.000239	CcSEcCtD
Risperidone—Anxiety—Epirubicin—testicular cancer	9.6e-05	0.000238	CcSEcCtD
Risperidone—Skin disorder—Methotrexate—testicular cancer	9.59e-05	0.000238	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	9.57e-05	0.000238	CcSEcCtD
Risperidone—Hyperhidrosis—Methotrexate—testicular cancer	9.54e-05	0.000237	CcSEcCtD
Risperidone—Discomfort—Epirubicin—testicular cancer	9.52e-05	0.000236	CcSEcCtD
Risperidone—Malaise—Doxorubicin—testicular cancer	9.45e-05	0.000234	CcSEcCtD
Risperidone—Dry mouth—Epirubicin—testicular cancer	9.43e-05	0.000234	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—testicular cancer	9.41e-05	0.000234	CcSEcCtD
Risperidone—Anorexia—Methotrexate—testicular cancer	9.41e-05	0.000234	CcSEcCtD
Risperidone—Syncope—Doxorubicin—testicular cancer	9.39e-05	0.000233	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—testicular cancer	9.38e-05	0.000233	CcSEcCtD
Risperidone—Confusional state—Epirubicin—testicular cancer	9.32e-05	0.000231	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—testicular cancer	9.26e-05	0.00023	CcSEcCtD
Risperidone—Oedema—Epirubicin—testicular cancer	9.24e-05	0.000229	CcSEcCtD
Risperidone—Anaphylactic shock—Epirubicin—testicular cancer	9.24e-05	0.000229	CcSEcCtD
Risperidone—Hypotension—Methotrexate—testicular cancer	9.22e-05	0.000229	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—testicular cancer	9.21e-05	0.000229	CcSEcCtD
Risperidone—Infection—Epirubicin—testicular cancer	9.18e-05	0.000228	CcSEcCtD
Risperidone—Cough—Doxorubicin—testicular cancer	9.14e-05	0.000227	CcSEcCtD
Risperidone—Shock—Epirubicin—testicular cancer	9.09e-05	0.000226	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—testicular cancer	9.07e-05	0.000225	CcSEcCtD
Risperidone—Nervous system disorder—Epirubicin—testicular cancer	9.06e-05	0.000225	CcSEcCtD
Risperidone—Thrombocytopenia—Epirubicin—testicular cancer	9.05e-05	0.000225	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—testicular cancer	9.04e-05	0.000224	CcSEcCtD
Risperidone—Tachycardia—Epirubicin—testicular cancer	9.02e-05	0.000224	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methotrexate—testicular cancer	8.99e-05	0.000223	CcSEcCtD
Risperidone—Skin disorder—Epirubicin—testicular cancer	8.97e-05	0.000223	CcSEcCtD
Risperidone—Hyperhidrosis—Epirubicin—testicular cancer	8.93e-05	0.000222	CcSEcCtD
Risperidone—Insomnia—Methotrexate—testicular cancer	8.93e-05	0.000222	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—testicular cancer	8.92e-05	0.000221	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—testicular cancer	8.92e-05	0.000221	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—testicular cancer	8.92e-05	0.000221	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—testicular cancer	8.89e-05	0.000221	CcSEcCtD
Risperidone—Paraesthesia—Methotrexate—testicular cancer	8.86e-05	0.00022	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	8.86e-05	0.00022	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—testicular cancer	8.81e-05	0.000219	CcSEcCtD
Risperidone—Anorexia—Epirubicin—testicular cancer	8.81e-05	0.000219	CcSEcCtD
Risperidone—Dyspnoea—Methotrexate—testicular cancer	8.8e-05	0.000218	CcSEcCtD
Risperidone—Somnolence—Methotrexate—testicular cancer	8.78e-05	0.000218	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—testicular cancer	8.72e-05	0.000216	CcSEcCtD
Risperidone—Dyspepsia—Methotrexate—testicular cancer	8.69e-05	0.000216	CcSEcCtD
Risperidone—Hypotension—Epirubicin—testicular cancer	8.63e-05	0.000214	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—testicular cancer	8.62e-05	0.000214	CcSEcCtD
Risperidone—Decreased appetite—Methotrexate—testicular cancer	8.58e-05	0.000213	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—testicular cancer	8.55e-05	0.000212	CcSEcCtD
Risperidone—Oedema—Doxorubicin—testicular cancer	8.55e-05	0.000212	CcSEcCtD
Risperidone—Gastrointestinal disorder—Methotrexate—testicular cancer	8.52e-05	0.000212	CcSEcCtD
Risperidone—Fatigue—Methotrexate—testicular cancer	8.51e-05	0.000211	CcSEcCtD
Risperidone—Infection—Doxorubicin—testicular cancer	8.49e-05	0.000211	CcSEcCtD
Risperidone—Pain—Methotrexate—testicular cancer	8.44e-05	0.00021	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Epirubicin—testicular cancer	8.42e-05	0.000209	CcSEcCtD
Risperidone—Shock—Doxorubicin—testicular cancer	8.41e-05	0.000209	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—testicular cancer	8.38e-05	0.000208	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—testicular cancer	8.37e-05	0.000208	CcSEcCtD
Risperidone—Insomnia—Epirubicin—testicular cancer	8.36e-05	0.000207	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—testicular cancer	8.34e-05	0.000207	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—testicular cancer	8.3e-05	0.000206	CcSEcCtD
Risperidone—Paraesthesia—Epirubicin—testicular cancer	8.3e-05	0.000206	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—testicular cancer	8.26e-05	0.000205	CcSEcCtD
Risperidone—Dyspnoea—Epirubicin—testicular cancer	8.24e-05	0.000204	CcSEcCtD
Risperidone—Somnolence—Epirubicin—testicular cancer	8.21e-05	0.000204	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—testicular cancer	8.15e-05	0.000202	CcSEcCtD
Risperidone—Feeling abnormal—Methotrexate—testicular cancer	8.13e-05	0.000202	CcSEcCtD
Risperidone—Dyspepsia—Epirubicin—testicular cancer	8.13e-05	0.000202	CcSEcCtD
Risperidone—Gastrointestinal pain—Methotrexate—testicular cancer	8.07e-05	0.0002	CcSEcCtD
Risperidone—Decreased appetite—Epirubicin—testicular cancer	8.03e-05	0.000199	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—testicular cancer	7.99e-05	0.000198	CcSEcCtD
Risperidone—Gastrointestinal disorder—Epirubicin—testicular cancer	7.98e-05	0.000198	CcSEcCtD
Risperidone—Fatigue—Epirubicin—testicular cancer	7.96e-05	0.000198	CcSEcCtD
Risperidone—Pain—Epirubicin—testicular cancer	7.9e-05	0.000196	CcSEcCtD
Risperidone—Constipation—Epirubicin—testicular cancer	7.9e-05	0.000196	CcSEcCtD
Risperidone—Urticaria—Methotrexate—testicular cancer	7.84e-05	0.000195	CcSEcCtD
Risperidone—Abdominal pain—Methotrexate—testicular cancer	7.8e-05	0.000194	CcSEcCtD
Risperidone—Body temperature increased—Methotrexate—testicular cancer	7.8e-05	0.000194	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	7.79e-05	0.000193	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—testicular cancer	7.73e-05	0.000192	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—testicular cancer	7.68e-05	0.000191	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—testicular cancer	7.62e-05	0.000189	CcSEcCtD
Risperidone—Feeling abnormal—Epirubicin—testicular cancer	7.61e-05	0.000189	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—testicular cancer	7.6e-05	0.000189	CcSEcCtD
Risperidone—Gastrointestinal pain—Epirubicin—testicular cancer	7.55e-05	0.000188	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—testicular cancer	7.52e-05	0.000187	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—testicular cancer	7.43e-05	0.000184	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—testicular cancer	7.38e-05	0.000183	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—testicular cancer	7.37e-05	0.000183	CcSEcCtD
Risperidone—Urticaria—Epirubicin—testicular cancer	7.34e-05	0.000182	CcSEcCtD
Risperidone—Pain—Doxorubicin—testicular cancer	7.31e-05	0.000181	CcSEcCtD
Risperidone—Constipation—Doxorubicin—testicular cancer	7.31e-05	0.000181	CcSEcCtD
Risperidone—Abdominal pain—Epirubicin—testicular cancer	7.3e-05	0.000181	CcSEcCtD
Risperidone—Body temperature increased—Epirubicin—testicular cancer	7.3e-05	0.000181	CcSEcCtD
Risperidone—Hypersensitivity—Methotrexate—testicular cancer	7.27e-05	0.000181	CcSEcCtD
Risperidone—Asthenia—Methotrexate—testicular cancer	7.08e-05	0.000176	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—testicular cancer	7.04e-05	0.000175	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—testicular cancer	6.99e-05	0.000174	CcSEcCtD
Risperidone—Pruritus—Methotrexate—testicular cancer	6.98e-05	0.000173	CcSEcCtD
Risperidone—Hypersensitivity—Epirubicin—testicular cancer	6.81e-05	0.000169	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—testicular cancer	6.79e-05	0.000169	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—testicular cancer	6.76e-05	0.000168	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—testicular cancer	6.76e-05	0.000168	CcSEcCtD
Risperidone—Diarrhoea—Methotrexate—testicular cancer	6.75e-05	0.000168	CcSEcCtD
Risperidone—Asthenia—Epirubicin—testicular cancer	6.63e-05	0.000165	CcSEcCtD
Risperidone—Pruritus—Epirubicin—testicular cancer	6.54e-05	0.000162	CcSEcCtD
Risperidone—Dizziness—Methotrexate—testicular cancer	6.53e-05	0.000162	CcSEcCtD
Risperidone—Diarrhoea—Epirubicin—testicular cancer	6.32e-05	0.000157	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—testicular cancer	6.3e-05	0.000156	CcSEcCtD
Risperidone—Vomiting—Methotrexate—testicular cancer	6.28e-05	0.000156	CcSEcCtD
Risperidone—Rash—Methotrexate—testicular cancer	6.22e-05	0.000155	CcSEcCtD
Risperidone—Dermatitis—Methotrexate—testicular cancer	6.22e-05	0.000154	CcSEcCtD
Risperidone—Headache—Methotrexate—testicular cancer	6.18e-05	0.000154	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—testicular cancer	6.13e-05	0.000152	CcSEcCtD
Risperidone—Dizziness—Epirubicin—testicular cancer	6.11e-05	0.000152	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—testicular cancer	6.05e-05	0.00015	CcSEcCtD
Risperidone—Vomiting—Epirubicin—testicular cancer	5.87e-05	0.000146	CcSEcCtD
Risperidone—Nausea—Methotrexate—testicular cancer	5.86e-05	0.000146	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—testicular cancer	5.85e-05	0.000145	CcSEcCtD
Risperidone—Rash—Epirubicin—testicular cancer	5.82e-05	0.000145	CcSEcCtD
Risperidone—Dermatitis—Epirubicin—testicular cancer	5.82e-05	0.000144	CcSEcCtD
Risperidone—Headache—Epirubicin—testicular cancer	5.79e-05	0.000144	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—testicular cancer	5.65e-05	0.00014	CcSEcCtD
Risperidone—Nausea—Epirubicin—testicular cancer	5.49e-05	0.000136	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—testicular cancer	5.43e-05	0.000135	CcSEcCtD
Risperidone—Rash—Doxorubicin—testicular cancer	5.39e-05	0.000134	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—testicular cancer	5.38e-05	0.000134	CcSEcCtD
Risperidone—Headache—Doxorubicin—testicular cancer	5.36e-05	0.000133	CcSEcCtD
Risperidone—Nausea—Doxorubicin—testicular cancer	5.08e-05	0.000126	CcSEcCtD
